LOC283129 Inhibitors
LOC283129 inhibitors encompass a range of compounds that indirectly impact the functional activity of the protein LOC283129, also known as MAJIN. These inhibitors exert their effects by interacting with processes and signaling pathways that LOC283129 is involved in. For instance, rapamycin's inhibition of mTOR leads to a general decrease in cellular metabolism and protein synthesis, which can negatively impact the energy-dependent processes that LOC283129 is a part of, such as cell membrane repair.
Compounds such as cyclosporine A, which targets T-cell activation, indirectly affect LOC283129 by reducing the immune cell responses that it may be involved in. Paclitaxel's ability to halt the cell cycle could prevent LOC283129 from participating in cell division, while bortezomib and MG132, as proteasome inhibitors, could inhibit LOC283129 activity by interfering with protein turnover mechanisms that are crucial for its function. Trichostatin A and wiskostatin perturb gene expression and actin filament assembly, respectively, both of which can indirectly reduce LOC283129 activity if it relies on these cellular components.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, which reduces protein synthesis and cell proliferation. MAJIN is involved in cell membrane repair and cell fusion, processes that are energy-intensive and may be hindered by the reduced metabolic activity that results from mTOR inhibition. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A inhibits calcineurin, thereby preventing the activation of T-cells. As MAJIN is involved in immune cell function, specifically in the cell fusion process during the immune response, its activity can be indirectly inhibited by suppressing T-cell activation. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and halts the cell cycle in the M phase. Given that MAJIN is implicated in cellular processes that are active during cell division, its function can be indirectly inhibited by preventing cells from progressing through mitosis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can disrupt protein turnover. If MAJIN requires regulated proteasomal degradation for its activation or function, bortezomib could inhibit its activity by preventing this process. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), which can lead to changes in chromatin structure and gene expression. If expression of MAJIN is regulated by HDACs, its activity could be indirectly reduced by such inhibitors. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is a specific inhibitor of the N-WASP, which is essential for actin filament assembly. As MAJIN is involved in cellular processes that require cytoskeletal reorganization, inhibition of N-WASP could lead to a decrease in MAJIN activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose is a glucose analog that inhibits glycolysis. Since MAJIN's membrane repair function is energy-dependent, hindering ATP production via glycolysis can indirectly inhibit its function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a reversible proteasome inhibitor that can prevent the degradation of ubiquitin-conjugated proteins. If the functionality of MAJIN is contingent upon such degradation, MG132 could lead to a reduction in its activity. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C is an alkylating agent that crosslinks DNA, leading to inhibition of DNA replication. Because MAJIN is involved in cellular processes during the cell cycle, DNA damage and subsequent cell cycle arrest can inhibit its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, leading to the inhibition of the AKT signaling pathway. As MAJIN may rely on AKT pathway signals for its activity, such as during cell membrane repair, PI3K inhibition could reduce its functional activity. | ||||||